Halozyme Therapeutics Inc (HALO)
38.57
+0.11
(+0.29%)
USD |
NASDAQ |
Apr 26, 16:00
38.45
-0.12
(-0.31%)
After-Hours: 20:00
Halozyme Therapeutics 1 Year Total Returns (Daily): 17.38% for April 26, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 26, 2024 | 17.38% |
April 25, 2024 | 14.57% |
April 24, 2024 | 16.64% |
April 23, 2024 | 13.71% |
April 22, 2024 | 12.96% |
April 19, 2024 | 9.87% |
April 18, 2024 | 5.88% |
April 17, 2024 | 5.61% |
April 16, 2024 | 7.66% |
April 15, 2024 | 8.61% |
April 12, 2024 | 6.25% |
April 11, 2024 | 7.02% |
April 10, 2024 | 6.16% |
April 09, 2024 | 4.70% |
April 08, 2024 | 4.12% |
April 05, 2024 | 9.72% |
April 04, 2024 | 6.03% |
April 03, 2024 | 3.85% |
April 02, 2024 | 5.87% |
April 01, 2024 | 8.20% |
March 28, 2024 | 11.42% |
March 27, 2024 | 14.09% |
March 26, 2024 | 16.21% |
March 25, 2024 | 17.19% |
March 22, 2024 | 21.97% |
Date | Value |
---|---|
March 21, 2024 | 16.28% |
March 20, 2024 | 15.97% |
March 19, 2024 | 23.37% |
March 18, 2024 | 22.04% |
March 15, 2024 | 2.02% |
March 14, 2024 | -2.88% |
March 13, 2024 | -3.64% |
March 12, 2024 | 0.77% |
March 11, 2024 | -1.03% |
March 08, 2024 | -1.83% |
March 07, 2024 | -3.89% |
March 06, 2024 | -8.33% |
March 05, 2024 | -10.70% |
March 04, 2024 | -11.73% |
March 01, 2024 | -13.67% |
February 29, 2024 | -17.05% |
February 28, 2024 | -17.30% |
February 27, 2024 | -17.94% |
February 26, 2024 | -19.92% |
February 23, 2024 | -19.44% |
February 22, 2024 | -20.69% |
February 21, 2024 | -22.75% |
February 20, 2024 | -28.04% |
February 16, 2024 | -26.72% |
February 15, 2024 | -27.01% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-37.83%
Minimum
Jan 10 2024
208.0%
Maximum
Mar 18 2021
25.56%
Average
10.95%
Median
May 26 2022
1 Year Total Returns (Daily) Benchmarks
Globus Medical Inc | -12.33% |
Denali Therapeutics Inc | -36.68% |
Johnson & Johnson | -7.38% |
AIM ImmunoTech Inc | -13.42% |
Protalix BioTherapeutics Inc | -57.41% |